SCHEMBL6277196

SCHEMBL6277196

CC(C)=CCOc1c(O)c2cc(OCC(=O)O)ccc2oc1=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.52
▸ KDM4E B2RXH2 6/20 0.52
▸ HPGD P15428 4/20 0.52
▸ LMNA P02545 3/20 0.49
▸ LOXL2 Q9Y4K0 1/20 0.47
▸ TSHR P16473 2/20 0.46
▸ AKR1C3 P42330 1/20 0.46
▸ AKR1C2 P52895 1/20 0.46
▸ AKR1C1 Q04828 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ MTNR1A P48039 2/20 0.45
▸ MAPT P10636 3/20 0.44
▸ GAA P10253 3/20 0.44
▸ KMT2A Q03164 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ NR1I2 O75469 1/20 0.43
▸ PGR P06401 1/20 0.43
▸ ADRB2 P07550 1/20 0.43
▸ ADRB1 P08588 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6276063 0.91 AKR1C3 (0.55) ALDH1A1KDM4EHPGDLMNAAKR1C3
SCHEMBL6274306 0.91 MGAM (0.55) ALDH1A1KDM4EHPGDLMNATSHR
SCHEMBL6274311 0.91 MGAM (0.55) ALDH1A1KDM4EHPGDLMNATSHR
SCHEMBL6274711 0.89 ACSL1 (0.48) ALDH1A1KDM4EHPGDLMNATSHR
SCHEMBL6272716 0.86 TDP1 (0.46) ALDH1A1KDM4EHPGDLMNATSHR
SCHEMBL6273079 0.85 KDM4E (0.57) ALDH1A1KDM4EHPGDLMNALOXL2
SCHEMBL6277921 0.84 KDM4E (0.58) ALDH1A1KDM4EHPGDLMNALOXL2
SCHEMBL6271415 0.84 TDP1 (0.45) ALDH1A1KDM4EHPGDLMNATSHR
SCHEMBL6276175 0.83 KDM4E (0.55) ALDH1A1KDM4EHPGDLMNALOXL2
SCHEMBL6276094 0.83 KDM4E (0.55) ALDH1A1KDM4EHPGDLMNALOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1273578-B1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK & CHEMICALS (JP) 2005-02-23 — — EP disclosed
US-6670391-B2 For inhibiting both immediate and delayed type allergic reactions; side effect reduction DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-12-30 — — US disclosed
US-20030096860-A1 Benzopyran derivative and antiallergic agent DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-05-22 — — US disclosed
EP-1273578-A1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-01-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096860-A1 Benzopyran derivative and antiallergic agent HRH2, HRH1, HRH4 ALDH1A1 105/4885KDM4E 965/4885HPGD 324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback